SEC Form 4 research
| Issuer | Flex Pharma, Inc. |
|---|---|
| Tickers | FLKS, SLRX, DCOY |
| Reporting owners | 34 |
| Officers and directors | 14 |
| Last public filing | 2026-09-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-09-02 | 2026-08-31 | Gauthier Patricia G. | A | 2,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Marschel Peter Klaus | A | 3,900 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Hibner Barbara Louise | A | 4,216 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Burleson Tess | A | 2,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | McVicar William K. | A | 3,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Lammers Paul | A | 2,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Rosenblum Mark J | A | 9,682 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | HANISH ARNOLD C | A | 3,000 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | PIERCE FREDERICK II | A | 33,455 | $0 | Not reported |
| 2026-09-02 | 2026-08-31 | Lieber Jonathan I | A | 2,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.